Merck KGaA (FRA:MRK)

Market Cap	54.89B
Revenue (ttm)	21.16B
Net Income (ttm)	2.78B
Shares Out	n/a
EPS (ttm)	6.39
PE Ratio	19.77
Forward PE	14.12
Dividend	2.20 (1.77%)
Ex-Dividend Date	Apr 28, 2025

Volume	n/a
Average Volume	967
Open	124.60
Previous Close	125.40
Day's Range	124.60 - 126.45
52-Week Range	108.00 - 176.50
Beta	n/a
RSI	55.61
Earnings Date	May 15, 2025

About Merck KGaA

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector. This segment provides drug manufacturers with process development expertise and technologies, such as continuous bioprocessing; testing kits and services; reagents and services; testing solutions that analyze air, water, and soil; and testing a...

• Industry: Pharmaceutical Preparations
• Founded: 1668
• Employees: 59,020
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: MRK

Financial Performance

In 2024, Merck KGaA's revenue was 21.16 billion, an increase of 0.78% compared to the previous year's 20.99 billion. Earnings were 2.78 billion, a decrease of -1.66%.